Retrospective study of preterm infants exposed to inhaled nitric oxide in Kaiser Permanente Southern California: morbidity, mortality and follow-up

期刊论文
出版模式：

开放获取
发表日期：

2024年7月18日

查看全文

Dilip R. Bhatt,
David Braun,
Roman Angelo Dizon,
Jiaxiao M. Shi,
Sunjeeve Weerasinghe,
Alex Sabio,
Siva Reddy,
Henry C. Lee,
Rangasamy Ramanathan,
Satyan Lakshminrusimha

摘要

Objective

Describe characteristics of preterm infants exposed to inhaled nitric oxide (iNO) in Kaiser Permanente Southern California.

Study design

Case review of preterm infants <34-weeks exposed to iNO during 2010–2020 including respiratory and echocardiographic status, NICU course, and 12-month follow-up.

Results

270 infants, 2.63% of births<34 weeks, (median, range: 26.1, 22^5/7–33^6/7 weeks gestation) were exposed to iNO. Median FiO₂ at iNO initiation was 1.0 (IQR 0.94-1.0). Pulmonary hypertension (PH) was not associated with risk-adjusted 2 h oxygenation response or improved survival. Mortality to NICU discharge was 37.4%. Median cost of iNO was $7,695/patient. Discharged survivors experienced frequent rehospitalization (34.9%), use of supplemental oxygen, sildenafil, diuretics, bronchodilators, and steroids. Four infants had persistent PH. Five infants died after NICU discharge.

Conclusions

Preterm infants receiving iNO have high mortality and 1st year morbidity. As currently used, iNO may be an indicator of respiratory disease severity rather than mediator of improved outcomes.